•  
  •  
  •  
  •  

2025-11-25 17:22:07

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Zydus receives final approval from USFDA for Verapamil Hydrochloride Extended-Release Tablets USP, 120 mg, 180 mg and 240 mg
  • Firstsource recognized as a 'Leader' in Digital Operations in ISG Provider LensĀ® 2025
  • Jyoti Ltd secures LOI from GETCO
  • HCLTech signs strategic collaboration agreement with AWS
  • DCW completes 100 years since laying of foundation stone at Dhrangadhra

Keywords Selected:  OpenOffer

Stock Report

  • Universal Halwasiya Group Successfully Completes Rs. 113-Crore Open Offer of Cupid Limited
  • Religare Enterprises - Public Announcement for Open Offer made by the Burman Group
  • Ambuja Cements acquires Sanghi Industries at an Enterprise Value of Rs 5,000 Crores
  • Ipca Laboratories Ltd to acquire majority stake in Unichem Laboratories Ltd
  • Advent announces Open offer for Suven Pharma at Rs. 495 per share
  • Swan Energy Ltd to acquire Veritas India Ltd
  • Open Offer for Selan Exploration Technology announced at Rs. 200 per share
  • Open offer for Eureka Forbes Ltd at Rs. 210.15 per share
  • Crompton Greaves Consumer Electricals announces open offer to acquire 26% in Butterfly Gandhimathi Appliances Ltd
  • H G Industries Ltd becomes subsidiary of Greenlam Industries Limited
  • Kirloskar Ferrous Industries Ltd to acquire ISMT Ltd
  • IPCA Laboratories Ltd to acquire majority stake in Lyka Labs Ltd

Latest Post

  • Zydus receives final approval from USFDA for Verapamil Hydrochloride Extended-Release Tablets USP, 120 mg, 180 mg and 240 mg
  • Firstsource recognized as a 'Leader' in Digital Operations in ISG Provider LensĀ® 2025
  • Jyoti Ltd secures LOI from GETCO
  • HCLTech signs strategic collaboration agreement with AWS
  • DCW completes 100 years since laying of foundation stone at Dhrangadhra


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024